We noticed you’re blocking ads

Thanks for visiting CRSToday. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated.

In order to avoid adverse performance issues with this site, please white list https://crstoday.com in your ad blocker then refresh this page.

Need help? Click here for instructions.

Digital Supplement | Editorially independent content

IJC Recap: Pharmaceutical Management of Presbyopia, Lens-based Refractive Surgery, and a Protocol for Interventional Glaucoma

In the Innovation Journal Club (IJC) series on Eyetube.net, host I. Paul Singh, MD, of The Eye Centers of Racine & Kenosha in Wisconsin, interviews leading experts from across eye care subspecialties about emerging innovations and technologies that may prove influential to the real-world practice of ophthalmology. The series is editorially independent (supported by advertising from multiple companies), which allows the discussions to be broad in scope and candid in presentation. The following is a summary of three episodes in which Dr. Singh spoke with Marjan Farid, MD, about why eyecare providers may want to re-evaluate the role of pharmaceuticals in the management of presbyopia; with William F. Wiley, MD, about the future of lens-based refractive surgery; and with Christine M. Funke, MD, about a protocol for integrating interventional glaucoma into real-world practice.

author
I. Paul Singh, MD
  • President, The Eye Centers of Racine and Kenosha in Wisconsin
  • Member, GT Editorial Advisory Board
  • ipsingh@amazingeye.com
  • Financial disclosure: AbbVie/Allergan, Alcon, Bausch + Lomb, Ellex, Glaukos, iStar Medical, Ivantis, Kala Pharmaceuticals, New World Medical, Sight Sciences

NEXT IN THIS ISSUE